SCHEMBL6169954

SCHEMBL6169954

O=C(NCC1CC1)c1onc2cc(Br)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
RAB9A P51151 2/20 0.43
MLLT1 Q03111 1/20 0.42
GSK3B P49841 3/20 0.42
RXFP1 Q9HBX9 1/20 0.39
HDAC4 P56524 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
NPC1 O15118 1/20 0.39
AR P10275 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170192 0.81 TRPV1 (0.46) HIF1AMEN1KMT2ARAB9AMLLT1
SCHEMBL6170078 0.81 KMT2A (0.42) HIF1AMEN1KMT2AHPGDKDM4E
SCHEMBL3524477 0.80 SCD5 (0.47) HIF1AMEN1KMT2AHPGDKDM4E
SCHEMBL6169856 0.80 RAB9A (0.53) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL6168162 0.77 RXFP1 (0.40) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL17438051 0.73 PTPN1 (0.42) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL5404456 0.72 CHRNA7 (0.51)
SCHEMBL17454396 0.72 ALDH1A1 (0.40) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL17437997 0.72 MAPT (0.48) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL3520615 0.71 ACHE (0.43) HIF1AMEN1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531812-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2005-05-25 EP disclosed
WO-2004010995-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-05 WO disclosed